# Fubei Biotechnology (Suzhou)

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fubei-biotechnology-suzhou

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.4btechnologies.com
- Latest round: Series A (Feb 10, 2021)
- Investors on record: 6

## About

Established in 2017 and based in Suzhou, China, Fubei Biotechnology (Suzhou) operates as a neurological drug developer dedicated to providing novel medicines for neurodegenerative diseases and neurological injuries. The co-founder and CEO, Xiaoming Guan, has 27 years of R&D and leadership experience in the pharmaceutical industry.

Up to now, there are 9 innovative projects in the R&D pipeline, including small-molecule chemical drugs and large-molecule biologics. In addition, potential drug candidates FB1003 and FB1008 for the treatment of chronic pain and Alzheimer's disease are in the preclinical stage.

## Funding rounds

- Series A, Feb 10, 2021 — Gaorong Ventures, China Growth Capital, Foothill Ventures, Fukun Venture Capital, FC Capital - China, Inno Works

## Investors

- Gaorong Ventures (https://capitalatlas.ai/funds/gaorong-ventures) — Series A
- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Series A
- Foothill Ventures (https://capitalatlas.ai/funds/foothill-ventures) — Series A
- Fukun Venture Capital — Series A
- FC Capital - China (https://capitalatlas.ai/funds/fc-capital-china) — Series A
- Inno Works — Series A